Orthogen Continues to Make Dental Surgery Even More Effective

Logo

Springfield, NJ -- (SBWire) -- 08/03/2017 --Over the years, dentists, orthodontists, and other dental professionals have been beneficiaries to many new and exciting technologies that grant them improved standards of patient care. Dental bone grafting materials such as DentoGen and NanoGen have significantly increased the success rate of site grafts. Developments like these from a company like Orthogen allow dental professionals to perform oral surgeries much more efficiently.

Not only has Orthogen conceived such innovative products like Nanogen and Dentogen plus a multitude of other dental tools, but the company's Research and Development department is unparalleled. They were awarded a $500,000 grant from the Small Business Technology Transfer Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke, to research the practicality of a skeletally attached interface with both mechanical and electrical control. What they discovered was astounding.

In the USA, there are almost two million amputees. Over the past two decades, the technology available to assist amputees with their daily tasks has grown exponentially. Although, there is still much left to accomplish for these men and women to function as if they had their limbs.

Orthogen created a peripheral nerve interface that operates prosthetic limbs. This interface connects bone, tissue, and skin to a prosthetic's surface. The study produced promising results, but the company has its sights on developing synthetic bone grafts. Orthogen is seeking partners to sub-license this technology.

To find out more about Orthogen, their innovative products, or to purchase dental bone grafting material online, please visit their website at http://www.orthogencorp.com/.

About Orthogen, LLC
Originally a division of BioLok International, which is now merged with BioHorizons, Orthogen, LLC was established in 2007 to develop and market next generation bone-grafting products for orthopedic and dental applications. Dr. Sachin Mamidwar serves as CEO of the company whereas Dr. Harold Alexander, previously Director of Orthopedic research at the Hospital for Joint Diseases, New York, serves as the Chairman of the Board. Orthogen offers various products including DentoGen®, NanoGen, collagen membranes, related instruments and sutures for dental applications.

To inquire about the company's products and technologies, please call 877-336-8643.

Media Relations Contact

Andrew Foligno
http://orthogencorp.com/

View this press release online at: http://rwire.com/842806